These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 12741766)

  • 1. Long-term release and improved intracellular penetration of oligonucleotide-polyethylenimine complexes entrapped in biodegradable microspheres.
    De Rosa G; Quaglia F; Bochot A; Ungaro F; Fattal E
    Biomacromolecules; 2003; 4(3):529-36. PubMed ID: 12741766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sustained release of nanosized complexes of polyethylenimine and anti-TGF-beta 2 oligonucleotide improves the outcome of glaucoma surgery.
    Gomes dos Santos AL; Bochot A; Doyle A; Tsapis N; Siepmann J; Siepmann F; Schmaler J; Besnard M; Behar-Cohen F; Fattal E
    J Control Release; 2006 May; 112(3):369-81. PubMed ID: 16644054
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gel and solid matrix systems for the controlled delivery of drug carrier-associated nucleic acids.
    Fattal E; De Rosa G; Bochot A
    Int J Pharm; 2004 Jun; 277(1-2):25-30. PubMed ID: 15158966
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Poly(lactide-co-glycolide) microspheres for the controlled release of oligonucleotide/polyethylenimine complexes.
    De Rosa G; Quaglia F; La Rotonda MI; Appel M; Alphandary H; Fattal E
    J Pharm Sci; 2002 Mar; 91(3):790-9. PubMed ID: 11920765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biodegradable microparticles for the controlled delivery of oligonucleotides.
    De Rosa G; Quaglia F; La Rotonda M; Besnard M; Fattal E
    Int J Pharm; 2002 Aug; 242(1-2):225-8. PubMed ID: 12176251
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preparation and characterization of temperature-sensitive poly(N-isopropylacrylamide)-b-poly(D,L-lactide) microspheres for protein delivery.
    Liu SQ; Yang YY; Liu XM; Tong YW
    Biomacromolecules; 2003; 4(6):1784-93. PubMed ID: 14606909
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sustained delivery and expression of plasmid DNA based on biodegradable polyester, poly(D,L-lactide-co-4-hydroxy-L-proline).
    Li Z; Huang L
    J Control Release; 2004 Aug; 98(3):437-46. PubMed ID: 15312999
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new delivery system for antisense therapy: PLGA microspheres encapsulating oligonucleotide/polyethyleneimine solid complexes.
    De Rosa G; Bochot A; Quaglia F; Besnard M; Fattal E
    Int J Pharm; 2003 Mar; 254(1):89-93. PubMed ID: 12615416
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of process and formulation parameters on characteristics and internal morphology of poly(d,l-lactide-co-glycolide) microspheres formed by the solvent evaporation method.
    Mao S; Shi Y; Li L; Xu J; Schaper A; Kissel T
    Eur J Pharm Biopharm; 2008 Feb; 68(2):214-23. PubMed ID: 17651954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cationic microparticles consisting of poly(lactide-co-glycolide) and polyethylenimine as carriers systems for parental DNA vaccination.
    Oster CG; Kim N; Grode L; Barbu-Tudoran L; Schaper AK; Kaufmann SH; Kissel T
    J Control Release; 2005 May; 104(2):359-77. PubMed ID: 15907586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of lactide/glycolide ratio on the in vitro release of ganciclovir and its lipophilic prodrug (GCV-monobutyrate) from PLGA microspheres.
    Janoria KG; Mitra AK
    Int J Pharm; 2007 Jun; 338(1-2):133-41. PubMed ID: 17363204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biodegradable microspheres for prolidase delivery to human cultured fibroblasts.
    Lupi A; Perugini P; Genta I; Modena T; Conti B; Casado B; Cetta G; Pavanetto F; Iadarola P
    J Pharm Pharmacol; 2004 May; 56(5):597-603. PubMed ID: 15142336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fabrication of covered porous PLGA microspheres using hydrogen peroxide for controlled drug delivery and regenerative medicine.
    Bae SE; Son JS; Park K; Han DK
    J Control Release; 2009 Jan; 133(1):37-43. PubMed ID: 18838089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stabilization of protein encapsulated in poly(lactide-co-glycolide) microspheres by novel viscous S/W/O/W method.
    Lee ES; Kwon MJ; Lee H; Kim JJ
    Int J Pharm; 2007 Feb; 331(1):27-37. PubMed ID: 17027204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficiency of polyethylenimines and polyethylenimine-graft-poly (ethylene glycol) block copolymers to protect oligonucleotides against enzymatic degradation.
    Brus C; Petersen H; Aigner A; Czubayko F; Kissel T
    Eur J Pharm Biopharm; 2004 May; 57(3):427-30. PubMed ID: 15093589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Controlled delivery of plasmid DNA and siRNA to intracellular targets using ketalized polyethylenimine.
    Shim MS; Kwon YJ
    Biomacromolecules; 2008 Feb; 9(2):444-55. PubMed ID: 18186606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stabilization and encapsulation of a staphylokinase variant (K35R) into poly(lactic-co-glycolic acid) microspheres.
    He JT; Su HB; Li GP; Tao XM; Mo W; Song HY
    Int J Pharm; 2006 Feb; 309(1-2):101-8. PubMed ID: 16413979
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced intracellular uptake and inhibition of NF-kappaB activation by decoy oligonucleotide released from PLGA microspheres.
    De Rosa G; Maiuri MC; Ungaro F; De Stefano D; Quaglia F; La Rotonda MI; Carnuccio R
    J Gene Med; 2005 Jun; 7(6):771-81. PubMed ID: 15702489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Controlled release of PEI/DNA complexes from PLGA microspheres as a potent delivery system to enhance immune response to HIV vaccine DNA prime/MVA boost regime.
    Zhou X; Liu B; Yu X; Zha X; Zhang X; Wang X; Jin Y; Wu Y; Chen Y; Shan Y; Chen Y; Liu J; Kong W; Shen J
    Eur J Pharm Biopharm; 2008 Mar; 68(3):589-95. PubMed ID: 17950586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preparation and characterization of PLGA microspheres containing a staphylokinase variant (K35R).
    He JT; Tao XM; Mo W; Song HY
    Yao Xue Xue Bao; 2006 Jan; 41(1):12-8. PubMed ID: 16683521
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.